ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0654

Corneal Confocal Microscopy: An Ophthalmic Imaging Biomarker for Small Fiber Neuropathy in Systemic Lupus Erythematosus

Miral Gharib1, Georgios Baloglu Baloglu2, Soha Osman1, Rayaz A.Malik3 and Samar Alemadi4, 1hamad medical corporation, Doha, Qatar, 2Weill Cornell Medicine , Qatar, doha, 3Weill Cornell Medicine , Qatar, doha, Qatar, 4Hamad medical corporation, Doha, Qatar

Meeting: ACR Convergence 2024

Keywords: Neuropsychiatry, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multi-system autoimmune disease with frequent neuropsychiatric symptoms associated with poor outcomes. Small fiber neuropathy can cause intolerable pain and is an underdiagnosed neurological manifestation of SLE due to a normal or near-normal neurological examination and electrophysiological testing. Indeed, it is not included in the Neuropsychiatric SLE criteria, The purpose of this study was to evaluate the utility of corneal confocal microscopy (CCM) in identifying small nerve fiber damage in patients with SLE.

Methods: A cross-sectional study conducted over one year, included 59 SLE patients and 17 healthy controls. Inclusion criteria were adult patients (≥18years old) who satisfy at least four of (ACR) SLE classification criteria. Exclusion criteria were other causes of peripheral neuropathy, corneal trauma, dystrophy, surgery, severe dry eyes or allergy to local anesthetics. Subjects underwent clinical examinations, DN4 questionnaire, CCM, sudomotor function assessment and vibration perception threshold (VPT). The CCM outcome measures were corneal nerve fiber, length and branch density.  Basic descriptive statistics were reported as mean ± SD. The Pearson χ2 test was used to compare categorical variables. For all evaluations, a two-sided P value of less than 0.05 was considered statistically significant.

Results: There were no differences between SLE patients and controls for age (P = 0.07) and sex (P = 0.09). The mean time from the initial diagnosis of SLE was 8.7 ± 6.6 years. 37of 59 (62.7%) patients had moderate to high disease activity. Participants with SLE (n=59) had Lower corneal nerve branch density (CNBD) (P< 0.0001), lower fiber length (CNFL) and CNBD/CNFD ratio (P< 0.0001),Higher mature dendritic cell (DC) density (P< 0.0001), Higher VPT, Higher DN4 questionnaire for pain score, Comparable corneal nerve fiber density (CNFD) (P=0.25) and immature DC density (P=0.86) (Fig. 1,Table 1) ,Those with active SLE (n=37, 62.7%) had significantly lower Corneal branch-to-fiber ratio (P< 0.05) .Comparable CNFD (P=0.47), CNBD (P=0.31), CNFL (P=0.75), mature DC density (P=0.66), and immature DC density (P=0.78) compared to those with inactive SLE (n=22, 37.3%).Those with SLE and continuous pain (n=10, 17.2%) had significantly lower CNFD (P< 0.01) and CNFL (P< 0.05) ,Comparable mature and immature DC density (P=0.37-0.99) compared to those with transient (n=12, 20.7%) or recurrent pain (n=36, 62.1%). SLE patients reported more limitations in their daily roles due to physical health concerns, emotional issues, higher levels of fatigue, less social interaction, more pain, and a lower general health compared to healthy controls (P< 0.01-0.0001), with similar emotional well-being (P=0.07). In regression analysis, physical activity difficulties were significantly associated with reduced CNBD, CNFL, and CNBD/CNFD ratio (P< 0.05).

Conclusion: Corneal confocal microscopy (CCM), A non-invasive imaging modality detects small nerve fiber damage in patients with SLE, particularly in those with neuropathic pain encouraging the utility of CCM as a surrogate marker of neurodegeneration for SLE.

Supporting image 1

Figure 1 shows the corneal nerve morphology of a healthy control from an original image (A), and analyzed image (B), a patient with systemic lupus erythematosus from an original (c) and analyzed image (D).

Supporting image 2

Table 1. Comparison of neuropathy measures and quality of life characteristics between healthy controls and subjects with systemic lupus erythematosus. Variables summarized as means ± standard deviation were compared using independent t-test. Abbreviations: corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL), corneal nerve fiber tortuosity (CNFT), inferior whorl length (IWL).


Disclosures: M. Gharib: None; G. Baloglu: None; S. Osman: None; R. A.Malik: None; S. Alemadi: None.

To cite this abstract in AMA style:

Gharib M, Baloglu G, Osman S, A.Malik R, Alemadi S. Corneal Confocal Microscopy: An Ophthalmic Imaging Biomarker for Small Fiber Neuropathy in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/corneal-confocal-microscopy-an-ophthalmic-imaging-biomarker-for-small-fiber-neuropathy-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/corneal-confocal-microscopy-an-ophthalmic-imaging-biomarker-for-small-fiber-neuropathy-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology